UBS is planning to sell its majority stake in Credit Suisse’s Chinese subsidiary to a Beijing-backed fund.
Novo Nordisk: The CEO is scheduled to appear before the US Senate on September 24. The company is investing $4.1 billion to expand production in the USA. Meanwhile, a generic version of…
© MarketScreener.com 2024
Novo Nordisk: The CEO is scheduled to appear before the US Senate on September 24. The company is investing $4.1 billion to expand production in the USA. Meanwhile, a generic version of…
© MarketScreener.com 2024